Cost Effectiveness of Treatments for Inflammatory Bowel Disease

Health-economic analysis: cost-effectiveness of scheduled maintenance treatment with infliximab for Crohn’s disease - modelling outcomes in active luminal and fistulizing disease in adults

(2010) J. LINDSAY et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

(2010) Jean Frédéric Colombel et al.   NEW ENGLAND JOURNAL OF MEDICINE

A cost-effectiveness analysis of MMX mesalazine compared with mesalazine in the treatment of mild-to-moderate ulcerative colitis from a UK perspective

(2010) Nic Brereton et al.   JOURNAL OF MEDICAL ECONOMICS

Cost-effectiveness of biological therapy for Crohn’s disease: Markov cohort analyses incorporating United Kingdom patient-level cost data

(2009) K. BODGER et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Cost-effectiveness of adalimumab for the maintenance of remission in patients with Crohnʼs disease

(2009) Edward V. Loftus et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Cost Effectiveness of Ibandronate for the Prevention of Fractures in Inflammatory Bowel Disease-Related Osteoporosis

(2009) Simon Kreck et al.   PHARMACOECONOMICS

The cumulative burden of oral corticosteroid side effects and the economic implications of steroid use

(2009) Stephanie C. Manson et al.   RESPIRATORY MEDICINE

The cost-utility of high dose oral mesalazine for moderately active ulcerative colitis

(2008) A. BUCKLAND et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

A model of the long-term cost effectiveness of scheduled maintenance treatment with infliximab for moderate-to-severe ulcerative colitis

(2008) H. H. TSAI et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Cost-Effectiveness of 5-Aminosalicylic Acid Therapy for Maintenance of Remission in Ulcerative Colitis

(2008) Eugene F. Yen et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Efficacy and Safety of Tumor Necrosis Factor Antagonists in Crohn's Disease: Meta-Analysis of Placebo-Controlled Trials

(2008) Laurent Peyrin–Biroulet et al.   Clinical Gastroenterology and Hepatology

Effects of Adalimumab Therapy on Incidence of Hospitalization and Surgery in Crohn's Disease: Results From the CHARM Study

(2008) Brian G. Feagan et al.   GASTROENTEROLOGY

Direct Health Care Costs of Crohn's Disease and Ulcerative Colitis in US Children and Adults

(2008) Michael D. Kappelman et al.   GASTROENTEROLOGY

Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort

(2008) F Schnitzler et al.   GUT

The Direct and Indirect Cost Burden of Crohnʼs Disease and Ulcerative Colitis

(2008) Teresa B. Gibson et al.   JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE

Loss of Treatment Response to Infliximab Maintenance Therapy in Crohn's Disease: A Payor Perspective

(2008) Eric Qiong Wu et al.   VALUE IN HEALTH

Health care and cost of medication for inflammatory bowel disease in the Rhein-Main region, Germany: A multicenter, prospective, internet-based study

(2007) I. Blumenstein et al.   INFLAMMATORY BOWEL DISEASES